About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Tg(Camk2a-cre)#Szi
transgene insertion, Scott Zeitlin
MGI:3811778
Summary 6 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
cn1
Uqcrfs1tm1Ctm/Uqcrfs1tm1Ctm
Tg(Camk2a-cre)#Szi/0
involves: 129 * C57BL/6 * C57BL/6J * CBA MGI:5444471
cn2
Ndufa5Gt(RRK279)Byg/Ndufa5Gt(RRK279)Byg
Tg(Camk2a-cre)#Szi/0
Tg(Gt(ROSA)26Sor-Ndufa5)#Ctm/0
involves: 129P2/OlaHsd * C57BL/6J * CBA * SJL MGI:5563770
cn3
Actbtm1(INSR)Dac/Actbtm1(INSR)Dac
Insrtm1Dac/Insrtm1Dac
Tg(Camk2a-cre)#Szi/?
involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6J * CBA MGI:4831152
cn4
Tsc1tm1Djk/Tsc1tm1Djk
Tg(Camk2a-cre)#Szi/0
involves: 129S4/SvJae * BALB/cJ * C57BL/6J * C57BL/6NTac * CBA MGI:3811792
cn5
Itga8tm1.1Rdav/Itga8tm1.1Rdav
Tg(Camk2a-cre)#Szi/0
involves: 129S6/SvEvTac * C57BL/6J * CBA MGI:4948114
cn6
Cox10tm1Ctm/Cox10tm1Ctm
Tg(Camk2a-cre)#Szi/0
involves: 129X1/SvJ * C57BL/6 * C57BL/6J * CBA MGI:5444474


Genotype
MGI:5444471
cn1
Allelic
Composition
Uqcrfs1tm1Ctm/Uqcrfs1tm1Ctm
Tg(Camk2a-cre)#Szi/0
Genetic
Background
involves: 129 * C57BL/6 * C57BL/6J * CBA
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tg(Camk2a-cre)#Szi mutation (0 available)
Uqcrfs1tm1Ctm mutation (0 available); any Uqcrfs1 mutation (19 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• sudden death between 3 and 3.5 months of age

growth/size/body
• mutants weight less than littermate controls, especially females

behavior/neurological
• decrease in rotarod performance at 2 months of age, with a rapid decline such that mutants are unable to perform the test 15 days later
• lower nocturnal ambulatory movement than controls

cellular
• mutants exhibit 43% and 40% of mitochondrial respiratory complex III (CIII) activity of control levels in cortex and hippocampus, respectively, at 1 month of age and 25% and 14% of control levels in cortex and hippocampus, respectively, at 110 days of age
• mutants exhibit an increase in enzymatic activity of mitochondrial respiratory complex IV (CIV) and citrate synthase of 114% and 115%, respectively, at 2.5 months of age in the cortex
• mutants exhibit an increase in enzymatic activity of CIV and citrate synthase to 120% and 121% of control values, respectively, in the hippocampus
• the ratio of ND1 to actin is higher in mutants at 3 months of age and there is a slight increase in mitochondrial proteins, indicating evidence of mitochondrial proliferation at this time

nervous system
• at 3 months of age
• neuronal cell death in the somatosensory cortex at 3 months of age right before their death, but not earlier
• mutants show oxidative damage in the piriform cortex by 1 month of age and neuronal cell death after 3 months of age
• mutants exhibit progressive encephalopathy, showing lesions in the piriform area at 66 days of age, which worsen and extend to posterior parts of the brain within 18 days
• mutants consistently show neuronal cell death in the somatosensory cortex, piriform cortex and hippocampus at 3 months of age right before their death, but not earlier
• neuronal cell death in the hippocampus at 3 months of age right before their death, but not earlier
• mutants exhibit a slight increase in GFAP immunoreactivity in the cortex, hippocampus, and piriform cortex at 3-3.5 months of age, indicating reactive glia

homeostasis/metabolism
• mutants exhibit decreased mitochondrial respiratory complex II enzymatic activity and increased enzymatic activity of mitochondrial respiratory complex IV and citrate synthase in the cortex and hippocampus

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
mitochondrial metabolism disease DOID:700 J:188773




Genotype
MGI:5563770
cn2
Allelic
Composition
Ndufa5Gt(RRK279)Byg/Ndufa5Gt(RRK279)Byg
Tg(Camk2a-cre)#Szi/0
Tg(Gt(ROSA)26Sor-Ndufa5)#Ctm/0
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6J * CBA * SJL
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ndufa5Gt(RRK279)Byg mutation (0 available); any Ndufa5 mutation (13 available)
Tg(Camk2a-cre)#Szi mutation (0 available)
Tg(Gt(ROSA)26Sor-Ndufa5)#Ctm mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
behavior/neurological
• at 10 to 11 months
• at 10 to 11 months
• at 10 to 11 months, mice exhibit longer latency in a pole descent test and reduced motor coordination in the grid and beam-walking tests compared with control mice

cellular
• mice exhibit complex I deficiency in the cortex compared with wild-type mice

nervous system
N
• at 11 months, cortex morphology is normal without oxidative damage




Genotype
MGI:4831152
cn3
Allelic
Composition
Actbtm1(INSR)Dac/Actbtm1(INSR)Dac
Insrtm1Dac/Insrtm1Dac
Tg(Camk2a-cre)#Szi/?
Genetic
Background
involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6J * CBA
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Actbtm1(INSR)Dac mutation (0 available); any Actb mutation (53 available)
Insrtm1Dac mutation (2 available); any Insr mutation (95 available)
Tg(Camk2a-cre)#Szi mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• die between 6 and 8 weeks

homeostasis/metabolism
• diabetic in one week
• extremely elevated




Genotype
MGI:3811792
cn4
Allelic
Composition
Tsc1tm1Djk/Tsc1tm1Djk
Tg(Camk2a-cre)#Szi/0
Genetic
Background
involves: 129S4/SvJae * BALB/cJ * C57BL/6J * C57BL/6NTac * CBA
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tg(Camk2a-cre)#Szi mutation (0 available)
Tsc1tm1Djk mutation (2 available); any Tsc1 mutation (71 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• mice die within the first postnatal week
• however, treatment with rapamycin improves phenotype

behavior/neurological
• mice clasp hindlimbs unlike wild-type mice
• however, treatment with rapamycin improves phenotype
• mice are severely hypoactive compared to wild-type mice
• however, treatment with rapamycin improves phenotype

nervous system
• brain weight is 2.5-fold greater than in wild-type mice
• however, treatment with rapamycin improves phenotype




Genotype
MGI:4948114
cn5
Allelic
Composition
Itga8tm1.1Rdav/Itga8tm1.1Rdav
Tg(Camk2a-cre)#Szi/0
Genetic
Background
involves: 129S6/SvEvTac * C57BL/6J * CBA
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Itga8tm1.1Rdav mutation (1 available); any Itga8 mutation (75 available)
Tg(Camk2a-cre)#Szi mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
nervous system
• N-methyl-D-aspartate receptor-dependent long term potentiation is lower than in wild-type mice
• N-methyl-D-aspartate receptor-dependent long term potentiation is lower than in wild-type mice

behavior/neurological
N
• mice exhibit normal motor learning, habituation, anxiety and hippocampal-dependent spatial learning, and memory




Genotype
MGI:5444474
cn6
Allelic
Composition
Cox10tm1Ctm/Cox10tm1Ctm
Tg(Camk2a-cre)#Szi/0
Genetic
Background
involves: 129X1/SvJ * C57BL/6 * C57BL/6J * CBA
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cox10tm1Ctm mutation (1 available); any Cox10 mutation (21 available)
Tg(Camk2a-cre)#Szi mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• die between 8 and 12 months of age

growth/size/body
• mutants weight less than littermate controls after 4 and 5 months of age, for females and males, respectively

behavior/neurological
• decrease in rotarod performance first seen at 3 and 4 months of age for males and females, respectively
• at 3 months of age, mutants start to decrease their nocturnal activity and by 4 months, cycles of hyperactivity are seen and continue throughout their life span

cellular
• mutants exhibit 80% of mitochondrial respiratory complex IV (CIV) activity of control levels in the cortex at 1 month of age and 33% of control levels by 4 months of age
• mutants exhibit decreased CIV activity in the hippocampus as well

nervous system
• brain weight is normal at 1-4 months of age, however by 8 months of age, brains weigh about half of control weight
• severe cortical atrophy by 8 months of age
• neuronal cell death in the cingulate cortex at 4 months of age, but not earlier
• mutants show oxidative damage in the piriform cortex at 4 months of age and neuronal cell death at this time but not earlier
• mutants exhibit progressive encephalopathy, with small lesions in the piriform cortex at 4 months of age, lesions in the striatum, outer cortical layers and hippocampus by 6 months of age, and massive degeneration of the cortex by 8 months of age
• mutants consistently show neuronal cell death in the cingulate cortex, piriform cortex, and hippocampus/dentate gyrus at 4 months of age, but not earlier
• the hippocampus/dentate gyrus and CA1 region shows neuronal loss at 4 months of age
• mutants show metabolic changes in the brain, with elevated levels of lactate and a decrease in n-acetyl aspartate
• mutants exhibit a dramatic increase in GFAP immunoreactivity in the cortex and somewhat smaller increase in the hippocampus and piriform cortex at 4-5 months of age, indicating reactive glia

homeostasis/metabolism
• mutants exhibit decreased mitochondrial respiratory complex IV enzymatic activity in the cortex and hippocampus

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
cytochrome-c oxidase deficiency disease DOID:3762 OMIM:PS220110
J:188773





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
12/10/2024
MGI 6.24
The Jackson Laboratory